Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC) - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)

Konferenzpapier/Poster - 28.09.2015

Siano Marco

Siano, Marco